FMC Anchorage in Anchorage, Alaska - Dialysis Center

FMC Anchorage is a medicare approved dialysis facility center in Anchorage, Alaska and it has 35 dialysis stations. It is located in Anchorage county at 3950 Laurel Street, Anchorage, AK, 99508. You can reach out to the office of FMC Anchorage at (907) 563-3149. This dialysis clinic is managed and/or owned by Renal Care Group Inc.. FMC Anchorage has the following ownership type - Profit. It was first certified by medicare in September, 1976. The medicare id for this facility is 022500 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC Anchorage
Location3950 Laurel Street, Anchorage, Alaska
No. of Dialysis Stations 35
Medicare ID022500
Managed ByRenal Care Group Inc.
Ownership TypeProfit
Late Shifts Yes

Contact Information


3950 Laurel Street, Anchorage, Alaska, 99508
(907) 563-3149

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC Anchorage from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1770695579
Organization NameRcg Anchorage
Doing Business AsRenal Care Group Alaska, Inc.
Address3950 Laurel St Anchorage, Alaska, 99508
Phone Number(907) 563-3149

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.83%67%
Patients who reported that nephrologists usually communicated and cared for them.6%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.11%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).67%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).25%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).8%14%

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.65%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.22%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.13%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).77%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).17%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).6%12%

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 84%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.16%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).79%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).12%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).9%12%

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data87
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL11

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center119
    Adult patient months included in Kt/V greater than or equal to 1.21177
    Percentage of adult patients getting regular hemodialysis at the center97

    News Archive

    Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

    In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

    Medical errors: The third cause of death in the US

    New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

    NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

    The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

    Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

    Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

    FDA approves marketing of first motorized device for patients with spinal cord injuries

    The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

    Read more Medical News

    › Verified 1 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center27
    Adult patient months included in Kt/V greater than or equal to 1.7196
    Percentage of adult patients getting regular peritoneal dialysis at the center95

    News Archive

    Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

    In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

    Medical errors: The third cause of death in the US

    New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

    NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

    The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

    Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

    Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

    FDA approves marketing of first motorized device for patients with spinal cord injuries

    The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

    Read more Medical News

    › Verified 1 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Anchorage with elevated calcium levels.

Patients with hypercalcemia149
Hypercalcemia patient months1474
Patients with Serumphosphor147
Patients with Serumphosphor less than 3.5 mg/dL12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL25
Patients with Serumphosphor from 5.6 to 7 mg/dL23
Patients with Serumphosphor greater than 7 mg/dL14

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 151
Patient months included in arterial venous fistula and catheter summaries 1097
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment69
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer13

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary137
Hospitalization Rate in facility123 (As Expected)
Hospitalization Rate: Upper Confidence Limit206.7
Hospitalization Rate: Lower Confidence Limit79.1

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at FMC Anchorage were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility16.3 (As Expected)
Readmission Rate: Upper Confidence Limit24.2
Readmission Rate: Lower Confidence Limit10.2

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Anchorage get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.68 (As Expected)
SIR: Upper Confidence Limit1.51
SIR: Lower Confidence Limit.25

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Anchorage's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 122
Transfusion Rate in facility26.8 (As Expected)
Transfusion Rate: Upper Confidence Limit58
Transfusion Rate: Lower Confidence Limit13.6

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at FMC Anchorage lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary778
Mortality Rate in facility18.1 (As Expected)
Mortality Rate: Upper Confidence Limit22.2
Mortality Rate: Lower Confidence Limit14.5

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago


Dialysis Facility in Anchorage, AK

FMC Anchorage
Location: 3950 Laurel Street, Anchorage, Alaska, 99508
Phone: (907) 563-3149
Liberty Dialysis - Alaska Llc
Location: 901 East Dimond Boulevard Suite G, Anchorage, Alaska, 99515
Phone: (907) 522-9009
FMC Cook Inlet
Location: 9085 Blackberry St, Anchorage, Alaska, 99502
Phone: (907) 868-1779
Denali Dialysis Center
Location: 360 Boniface Pkwy Suite A11, Anchorage, Alaska, 99504
Phone: (907) 332-2400
Tudor Dialysis
Location: 2735 E Tudor Rd, Anchorage, Alaska, 99507
Phone: (907) 562-1546

News Archive

Copenhagen Consensus report argues for addressing chronic, NCDs in developing countries

In the second part of a series of Slate articles highlighting issues being examined by the Copenhagen Consensus Center, Bjorn Lomborg, director of the center, examines the global burden of non-communicable diseases, which "receive the smallest amount of donor assistance of all health conditions, having lost ground since 1990 relative to infectious diseases," he writes.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus is a plant with a history as herbal medicine, containing many chemical substances frequently found to be drug-like in character: flavonoids, terpenoids, and the like. Compounds sourced from the plant have demonstrated some inhibitory activity against HIV by modulation of the CYP3A4 enzyme, and thus in a drug lead discovery effort, Kumar et al. (July 2021) computationally screened these natural compounds against MPRO in a paper recently published to Computers in Biology and Medicine.

FDA approves marketing of first motorized device for patients with spinal cord injuries

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury.

Read more Medical News

› Verified 1 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.